+91 8368715873 secretariat@haematocon2026.in
ISHBT Website Become ISHBT Member

Abstract Submission Guidelines

1. Abstract Categories
  • Clinical – Benign
    Anemias, Thalassemia, Bleeding disorders, ITP, Stem cell transplantation.
  • Clinical – Malignant
    Acute & chronic leukemias, Lymphomas, Plasma cell neoplasms, CAR-T therapies.
  • Laboratory Haematology – Benign
    Morphology, Flow cytometry, Coagulation assays, Molecular diagnostics.
  • Laboratory Haematology – Malignant
    Immunophenotyping, Cytogenetics, MRD assessment, Biomarkers.
  • Transfusion Medicine & Immunohematology
  • Scientific committee may reassign categories if required.
2. Eligibility & General Conditions
  • Registration is mandatory for all delegates.
  • Abstract must relate to Hematology.
  • Each delegate may submit maximum two abstracts.
  • Abstract must be written in English.
  • Incomplete abstracts will not be accepted.
3. Types of Submissions
  • Original research
  • Ongoing research
  • Preliminary data
  • Case reports
  • Hypothesis driven work
  • Thesis work
  • Review articles
4. Abstract Format
  • Word Limit: Maximum 300 words.
  • Original Research: Background • Objectives • Methods • Results • Conclusion
  • Case Reports: Background • Case Description • Discussion • Conclusion
  • Improperly structured abstracts will be rejected.
5. Formatting Instructions
  • Font: Times New Roman
  • Font Size: 12
  • Title: Bold
  • Presenting Author: Bold & Underlined
  • Affiliation: Institution, City, Country
  • No tables, graphs or images allowed.
6. Submission Process
  • Submission only through official portal.
  • Email submissions will not be accepted.
  • Confirmation will be sent via email.
  • Last Date: 31st July 2026
7. Review Process
  • Peer reviewed by scientific committee.
  • Evaluation based on scientific merit & originality.
  • Selected for Oral or Poster Presentation.
  • Committee decision is final.
8. Presentation Guidelines
  • Accepted presenters must follow deadlines.
  • Respond promptly to official communications.
  • Failure to comply may result in withdrawal.
9. Awards
  • Attractive awards will be presented in eligible categories.
Submit Abstract